Navigating the New Normal in the Transportation Industry as the Pandemic Continues

July 17, 2020

 

The last few months have been unprecedented in world history. The pandemic that is gripping the world has spared no country, culture or corner, and it has highlighted the gaps in many companies’...

Contract Pharma Features Cryoport Growth and Innovation

June 23, 2020

A new Contract Pharma article is all about Cryoport!

Life Sciences in 2020: Biospace Interviews Mark Sawicki on Impending Developments in Cell and Gene Therapy

January 03, 2020

Commercial Officer Mark Sawicki brings more than a sales background to the company: He also holds a Ph.D. in biochemistry and has a distinguished career in global biopharmaceutical development.  

...

The Future is Now: CCO Mark Sawicki Shares the Effects of New Technology on Cold Chain Logistics in Pharma Manufacturing

December 04, 2019

A new article for Pharma Manufacturing breaks down the technology innovations that are changing cold chain logistics.

Cryoport-Lonza Partnership Featured in Contract Pharma and Biopharma Dive

November 12, 2019

Cryoport is expanding its impact on regenerative medicine development and distribution via a new partnership with Lonza 

New Cryoport Partnerships Featured in Biopharma-Reporter, Contract Pharma, and PharmaExec.com

October 15, 2019

“The past year has seen Cryoport establish multiple collaborations and expansions of its offering,” says a new article in BioPharma-Reporter, “due to the booming cell and gene therapy space and...

As More Cell and Gene Therapies Go to Market, Manufacturing Challenges Abound: Cryoport’s Ryan Carpentier Predicts Important Industry Trends in Contract Pharma

September 24, 2019

With just a handful of cell and gene therapies currently on the market, we’ve only seen the tip of the iceberg. 

That’s how Cryoport’s Executive Director of Business Development, Ryan Carpentier,...

Ryan Carpentier Discusses CAR T Therapy Successes and Challenges in Contract Pharma

September 10, 2019

In a new article for Contract Pharma, Cryoport Executive Director of Business Development Ryan Carpentier explains the exciting new opportunities of CAR T-cell immunotherapy, which enables a...

New Cryoport-Vineti Partnership Provides Expanded Supply Chain Services for Cell and Gene Therapy Developers: Outsourcing Pharma, Pharmaceutical Commerce Publications

September 10, 2019

New articles in Outsourcing Pharma and Pharmaceutical Commerce highlight the exciting benefits of the recently announced partnership between Cryoport and Vineti

Life Science Leader Magazine Features Cryoport Board Member Robert Hariri, Stem Cell Research Pioneer and Celularity CEO

August 29, 2019

A new article in Life Science Leader chronicles the incredible achievements of Robert Hariri, M.D., Ph.D. The CEO of Celularity (a Cryoport-supported company) is also a neurosurgeon, a jet...

Cryoport’s Technology, Record-Breaking Q2 Earnings Featured in Outsourcing-Pharma

August 14, 2019

A special supply-chain focused edition of Outsourcing-Pharma highlights Cryoport’s new patent-pending technology and excellent Q2 earnings report.

2019 Has Been The Most Significant Year in Cryoport History – And It’s Not Over Yet

June 26, 2019

According to the well-known physics principle, an object in motion tends to stay in motion. That's been especially true at Cryoport over the past six months, as we’ve celebrated one big milestone...

Cryoport President and CEO Jerrell W. Shelton Discusses the ‘Robust Demand’ of the Cell Therapy Market with BioPharma-Reporter

April 22, 2019

Cryoport has experienced remarkable growth in the past year: the company opened facilities in Amsterdam and Livingston, N.J., expanded its animal health services, hired several new employees, and...

Be The Match BioTherapies, Cryoport Enter Agreement - Contract Pharma

October 04, 2018

Be The Match BioTherapies and Cryoport announced a strategic partnership to deliver end-to-end supply chain services to the cell and gene therapy industry. The collaboration will support both...

Cryoport, World Courier Ink Logistics Deal for Gene Therapies - Logistics for the Life Sciences

July 17, 2018

Cryoport, Inc. announced that World Courier, a part of AmerisourceBergen, will integrate Cryoport’s full suite of temperature-controlled products into its global network. This integrated platform...

Cryogenic Logistics Company Cryoport Grabs Contracts for Gilead, Novartis CAR-T Products - BioSpace Article

November 03, 2017

"In the world of developing and manufacturing cell-based therapeutics an approved medication for any indication is only part of the business plan. The other aspect is delivering the product to...

Cold Chain Market and Technology Trends

September 06, 2017

The cold chain pharmaceutical market continues to be one garnering specific interest within the logistics space. New therapies such as regenerative therapies and gene therapies as well as a shift...

CenterWatch Interview: Cryoport’s Chief Commercial Officer, Mark W. Sawicki, Ph.D., on a New Era of Logistics Challenges

August 22, 2016 Logistics, and particularly cold chain logistics, has taken an increasingly important role in the development of new therapeutics. With the advent of regenerative medicines and personalized...

Shipping Service Offers Cryogenic Transit and Storage

November 14, 2014 Through UPS’ Temperature True® Cryo service, UPS is broadening its temperature-sensitive shipping offerings to include cryogenic solutions for UPS health care customers by utilizing Cryoport’s...